---
title: Antimicrobial Susceptibility Testing
---

[Back to index](index.html)

---
# Clinical Microbiology
## Antimicrobial Susceptibility Testing

Antimicrobial Susceptibility Testing (AST) is a crucial component of clinical microbiology, designed to determine the efficacy of specific antibiotics against pathogens isolated from clinical specimens. This testing guides clinicians in selecting the most appropriate antimicrobial therapy for treating infections and helps in tracking the emergence of antibiotic resistance. Hereâ€™s a detailed overview of AST:

### Key Objectives:
- To identify which antibiotics are effective against a particular bacterial or fungal pathogen.
- To aid in optimizing patient treatment regimens.
- To monitor and track trends in antimicrobial resistance.

### Common Methods:
1. **Disk Diffusion (Kirby-Bauer Method):**
    - **Procedure:** Small disks impregnated with standardized concentrations of antibiotics are placed on an agar plate inoculated with the bacterial strain.
    - **Incubation:** The plate is incubated to allow bacterial growth.
    - **Interpretation:** Zones of inhibition (areas where bacteria do not grow) around the disks are measured. The size of these zones is compared to standardized charts to determine susceptibility or resistance.

2. **Broth Dilution Methods:**
    - **Macrobroth and Microbroth Dilution:**
        - **Procedure:** Bacterial cultures are exposed to varying concentrations of antibiotics in broth media.
        - **Minimum Inhibitory Concentration (MIC):** The lowest concentration of the antibiotic that inhibits visible bacterial growth is determined.
    - **Applications:** Can be performed in test tubes (macrobroth) or microtiter plates (microbroth).

3. **E-test (Epsilometer Test):**
    - **Procedure:** Strips containing a gradient of antibiotic concentrations are placed on an agar plate inoculated with the bacterial strain.
    - **Interpretation:** The point where the bacterial growth intersects the strip indicates the MIC.

4. **Automated Systems:**
    - **Systems:** Instruments like VITEK, BD Phoenix, and Microscan provide rapid, automated results.
    - **Method:** Utilize cards or panels with pre-dispensed antibiotics and automated reading of growth and MIC.

### Interpretation of Results:
Results are classified based on the MIC or zone of inhibition as:
- **Susceptible (S):** The pathogen is likely to be inhibited by the standard antibiotic dosage.
- **Intermediate (I):** The pathogen may be inhibited by a higher dosage of the antibiotic or in body sites where the drug is physiologically concentrated.
- **Resistant (R):** The pathogen is not inhibited by the standard dosage of the antibiotic.

### Clinical Implications:
- **Treatment Decisions:** Tailors antimicrobial therapy to the specific pathogen, improving treatment efficacy and reducing unnecessary antibiotic use.
- **Antibiotic Stewardship:** Helps in the rational use of antibiotics, curbing the spread of resistance.
- **Surveillance:** Facilitates monitoring trends in antimicrobial resistance, guiding public health interventions.

### Quality Control:
- **Standardization:** Adherence to guidelines provided by organizations like the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
- **Quality Control Strains:** Use of control strains with known susceptibilities to ensure accuracy and reliability of test results.

In summary, Antimicrobial Susceptibility Testing is an indispensable tool in clinical microbiology, crucial for guiding effective antimicrobial therapy and combating the growing issue of antibiotic resistance.

---
[Back to index](index.html)
